The Genetics of Migraine: Why It Runs in Families

People with migraine frequently report that a parent, sibling, or grandparent also experiences the condition. This is not coincidence. Migraine has a substantial genetic component, and the familial clustering of the condition reflects a biological reality that has been increasingly well characterized by genetic research over the past two decades. Understanding the genetics of migraine does not change how it is treated, but it changes how it is understood, and that understanding has real implications for how people with migraine think about their condition and discuss it with their families and healthcare providers.

The Heritability of Migraine

Twin studies are the most informative tool for estimating the genetic contribution to a complex condition. By comparing the concordance of migraine between identical twins, who share nearly all of their genetic material, and fraternal twins, who share approximately half, researchers can estimate how much of the variation in migraine risk is explained by genetics versus environment.

Multiple twin studies have produced consistent estimates. The heritability of migraine, meaning the proportion of variation in migraine risk explained by genetic factors, is approximately forty to sixty percent. This places migraine in the moderate to high range of heritability for complex neurological disorders. First-degree relatives of people with migraine have approximately three times the risk of the general population.

These figures mean that genetics is a significant but not deterministic factor. Having a parent with migraine substantially increases risk but does not guarantee the condition. Conversely, not having a family history of migraine does not eliminate risk, since the remaining forty to sixty percent of variation is explained by environmental, hormonal, and lifestyle factors.

The Genetic Architecture of Migraine

Migraine is not a single-gene disorder. With the exception of a rare subtype called familial hemiplegic migraine, in which mutations in specific genes produce a distinctive severe form of migraine with motor aura, common migraine results from the combined effect of many genetic variants, each contributing a small amount to overall risk.

Genome-wide association studies, which scan the entire genome for variants associated with a condition, have identified more than forty genetic loci associated with migraine risk. The genes implicated fall into several functional categories including those involved in glutamatergic signaling, pain sensitivity, vascular function, and ion channel regulation in neurons.

The glutamatergic findings are particularly informative. Glutamate is the primary excitatory neurotransmitter in the central nervous system, and variants in genes that regulate glutamate signaling are among the most consistently associated with migraine risk. This aligns with the broader understanding of migraine as a disorder of neuronal excitability, in which the threshold for triggering the cascade that produces an attack is lower in susceptible individuals.

Familial Hemiplegic Migraine

Familial hemiplegic migraine represents the best-characterized genetic form of migraine. It is caused by mutations in three genes: CACNA1A, which encodes a voltage-gated calcium channel; ATP1A2, which encodes a sodium-potassium ATPase; and SCN1A, which encodes a voltage-gated sodium channel. These mutations affect ion transport in neurons and increase susceptibility to cortical spreading depression, the neurological phenomenon that underlies migraine aura.

Familial hemiplegic migraine is rare, affecting approximately five in one hundred thousand people, but its study has provided important insights into the neurological mechanisms relevant to common migraine. The ion channel findings in familial hemiplegic migraine have informed the broader understanding of neuronal excitability as a central feature of migraine pathophysiology.

What Genetics Means for Diagnosis and Treatment

The genetic basis of migraine has several practical implications. First, it provides a biological explanation for why migraine runs in families that can help people understand their own condition and reduce the stigma sometimes associated with the diagnosis. Migraine is not a personality trait, a response to stress, or a sign of weakness. It is a genetically influenced neurological condition with the same biological legitimacy as any other heritable disorder.

Second, the genetic findings point toward biological pathways that are targets for treatment development. The identification of CGRP as a key mediator of migraine pain, which led to the development of CGRP monoclonal antibodies as preventive treatments, emerged partly from understanding the neurological mechanisms implicated by genetic research.

Third, genetic research is moving toward the possibility of using genetic profiles to predict treatment response. Different genetic variants may be associated with better responses to different medications, and as this research matures it may eventually support more personalized approaches to migraine treatment selection.

Talking to Family Members

Because migraine has a significant genetic component, people with the condition may find it useful to discuss their diagnosis with family members who experience similar symptoms. Many people with migraine remain undiagnosed for years or decades, sometimes because symptoms are normalized within families where migraine is common. A diagnosed family member can provide important context and encourage others to seek evaluation.

The familial pattern also means that children of people with migraine are at elevated risk and should be monitored for early signs of the condition, which in children often presents differently than in adults, frequently with shorter attacks, more prominent nausea, and bilateral rather than unilateral pain.